Your monthly investment remains predictable and transparent from your first 2.5 mg dose through therapeutic maintenance, allowing you to budget confidently for sustainable weight loss treatment
BMO Capital Markets analysts expect a slow launch, however, writing in a note to investors about challenges including a black box warning for risk of acute adrenal insufficiency or adrenal crisis with inadequate concomitant glucocorticoid therapy. The firm said it anticipates broad commercial access will not happen until the second half of 2025
In androgen-independent human prostate cancer PC-3 cells, antiproliferative effects were attributed to upregulated Cyr61 protein expression (28)
His expertise in weight management has transformed my life in ways I never thought possible
Maximum daily dose: 1200mg without medical supervision
What to Expect: A General Treatment Timeline Every patient responds differently to compounded tirzepatide with B12 for weight loss, and individual results will vary